GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
NCT06324461
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
372
Enrollment
OTHER
Sponsor class
Conditions
Myocardial Injury
Interventions
DRUG:
Dulaglutide 0.75mg subcutaneous injection
Sponsor
The University of Hong Kong
Collaborators
[object Object]